Dover Corp vs Edwards Lifesciences Corporation Common Stock — how do they compare? Dover Corp trades at $188.82 (market cap $25.45B), while Edwards Lifesciences Corporation Common Stock trades at $83.47 (market cap $48.56B). The key difference: Edwards Lifesciences Corporation Common Stock is the larger of the two by market cap, and Dover Corp pays a 1.11% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| DOV | EW | |
|---|---|---|
Market Cap | $25.45B | $48.56B |
Volume | 661,758 | 6,520,488 |
Sector | Industrials | Health |
52-Week High | $233.31 | $95.18 |
52-Week Low | $161.16 | $72.65 |
Typical Hold Time | 73 Days | — |
Enterprise Value | $26.95B | $45.01B |
Dividend Yield | 1.11% | — |
Signals from Pluang's Aura AI — not financial advice
Dover Corporation (DOV) trades at $188.29, down 1.87% with a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and healthy profitability (13.48% net margin, 14.98% ROE). Recent acquisitions of Cloeren and Leistung expand manufacturing capabilities, while analyst consensus remains strongly bullish with a $243.20 price target representing 29% upside potential.
The outlook remains positive given Dover's Dividend King status, strategic acquisitions, and Wall Street support. Key risks include cyclical industrial exposure and recent negative cash flow trends. With no analyst sell ratings and technical indicators suggesting potential oversold conditions, the stock presents a compelling opportunity for long-term investors despite near-term bearish technical signals.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →